# Study of Intragastric pH Profile After 5 Days Pantoprazole 40 mg iv Followed by Oral Esomeprazole 40 mg po or Oral Pantoprazole 40 mg po

> **NCT00206050** · PHASE4 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 40 (—)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Esomeprazole
- **DRUG:** pantoprazole

## Key facts

- **NCT ID:** NCT00206050
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2004-12
- **Final completion:** 2004-12
- **Target enrollment:** 40 (—)
- **Last updated:** 2011-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00206050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00206050, "Study of Intragastric pH Profile After 5 Days Pantoprazole 40 mg iv Followed by Oral Esomeprazole 40 mg po or Oral Pantoprazole 40 mg po". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00206050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*